Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ovulation inhibition study of two ethinylestradiol/gestodene transdermal patch formulations
2009-009177-10Phase 2Completed
- Sponsor
- Bayer
- Start
- Mar 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ethinyl estradiol and gestodene in contraception (2 arms), sponsored by Bayer. Primary endpoint: Ovulation in treatment cycles 2 and 3. Started Mar 2009; status: completed.
02
Drugs
ethinyl estradiolgestodene
03
Conditions
contraception
Beyond the preview
Go deeper on 2009-009177-10.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-009177-10.